This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

J&J Recall Slideshow: The Recalls of 2011 & 2010

(J&J recall slideshow updated with company's latest medicine recall)

NEW YORK (TheStreet) -- Medicine recalls that greatly defined Johnson & Johnson (JNJ) last year continue to pester the company in 2011.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Most recently, J&J's McNeil Consumer Healthcare division said it was recalling certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products as a precautionary measure. The unit said it was also recalling certain lots of Benadryl, Sudafed and Sinutab products for the same reason. In addition, the division was recalling lots of Rolaids Multi-Symptom Berry Tablets.





It could almost be said that recalls defined consumer giant J&J in 2010, as its McNeil Consumer Healthcare division recalled tens of millions of packages of over-the-counter medicines that year, and the parent faced criminal investigation by the U.S. Justice Department as federal regulators became alarmed.

In turn, as the reputation of one of the world's most trusted names in consumer products became tarnished, shares of the company fell about 4% over the year, under-performing the S&P 500, which rose about 13% over the same time period. OTC drugs weren't the only products recalled by J&J in 2010; products from contact lenses to hip replacement products were also recalled.

TheStreet has compiled photos of major over-the-counter product recalls by J&J, creating a gallery that serves as a portrayal of J&J's yearlong market debacle last year -- and any other possible debacles in 2011. Read on for more ...

Stock quotes in this article: JNJ 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs